1 / 35

PHIN Conference Atlanta, GA August 26, 2008

Tracking Influenza Vaccine Doses Administered: Pilot Test of CDC’s Countermeasure and Response Administration System. PHIN Conference Atlanta, GA August 26, 2008 Jeanne Santoli, MD, MPH 1 and Jeanne Tropper, MS, MPH 2 1 Immunization Services Division

arien
Télécharger la présentation

PHIN Conference Atlanta, GA August 26, 2008

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Tracking Influenza Vaccine Doses Administered: Pilot Test of CDC’s Countermeasure and Response Administration System PHIN Conference Atlanta, GA August 26, 2008 Jeanne Santoli, MD, MPH1 and Jeanne Tropper, MS, MPH2 1Immunization Services Division National Center for Infectious and Respiratory Diseases Centers for Disease Control and Prevention 2Division of Emergency Preparedness and Response National Center for Public Health Informatics Centers for Disease Control and Prevention

  2. Co-Authors • Jeanne Santoli, MD, MPH • Jeanne Tropper, MS, MPH • Tom Shimabukuro, MD, MBA, MPH • Sanjeeb Sapkota, MBBS, MPH • Warren Williams, MPH • Charles Williams, MPH, MA • Ulrica Andujar, MPH • Sabrina Walton, MPH

  3. Talk Outline • Background • 2007 Vaccine Doses Administered Pilot Results; Lessons Learned • 2008 Vaccine Doses Administered Exercise • Question and Answer

  4. Background • The National Strategy for Pandemic Influenza: Implementation Plan calls for monitoring appropriate use of scarce pre-pandemic/pandemic influenza vaccine • To accomplish this, Project Areas are expected to track pandemic influenza (PI) vaccine doses administered at the individual patient level and then send a subset of data (minimum data set) on a weekly basis to the CDC; Project Areas are the 50 states, 4 large cities and 8 territories • CDC’s CRA system has been modified to provide flexible ways for Project Areas to report vaccine doses administered

  5. PI Vaccine Doses Administered Minimum Data Set for Reporting to CDC • Project Area ID • Reporting Period Start and End Dates • Vaccine Type (CVX code) • HHS Pandemic Priority Groups • Homeland and Nations Security • Health Care and Community Support Services • Critical Infrastructure • General Population • Dose # • Count of Doses Administered per Priority Group and Dose #

  6. HHS Proposed Pandemic Priority Groups http://www.pandemicflu.gov/vaccine/allocationguidance.pdf

  7. Countermeasure Response & Administration (CRA) Overview • Genesis was Pre-Event Vaccination System (PVS) for national smallpox vaccination campaign • Capability to support mass tracking during an event • System has been evolved to support any countermeasure, any event • Includes the ability to track both detail (person level) and aggregate counts of countermeasures

  8. Aggregate Reporting Options The file is then securely transferred to CDC via either CRA application or PHIN MS and loaded into CRA for reporting State enter data into state’s Immunization Information System or some other equivalent application and is extracted in one of these format. Pipe-delimited File XML File Option 1 Data exchange CRA HL 7 Data is available in CRA for reporting Aggregate data entered directly into CRA via the web-based aggregate reporting interface CRA Option 2 Direct web entry Individual level data is entered directly into CRA via the web based flexible Treatment interface Individual level data are automatically aggregated by CRA system and is available for reporting Option 3 Individual level data entry CRA

  9. 2007 Aggregate Reporting Pilot Test To test the capability to monitor vaccines doses, a pilot using seasonal influenza vaccine as proxy for pandemic was developed Pilot Test Purpose: Project areas on ability to collect and report to CDC; access aggregate reports CDC assessed on technical capability of CRA to accept and aggregate data Exercise was designed to be minimally invasive to normal operations Time frame: November 1 – December 31, 2007 Frequency: Repeatable; at minimum - twice

  10. Pilot Minimum Data Set • Project Area ID • Date of Clinics • Age • 6 – 23 months • 2 – 18 years • 19 – 49 years • 50 – 64 years • 65+ years

  11. Parameters for Participation in 2007 Pilot Identify Point of Contact (POC) Select option choice Identify minimum of two clinic dates Send data for both clinics within 48 hours – “fully successful”

  12. 2007 Pilot Activities PA Tasks CDC Tasks Phase I: Pre-Pilot Planning Apr-Oct 2007 Phase II: Pilot Test Nov-Dec 2007 Phase III: Post-Pilot Jan-Mar 2008 • Webinars - Orientation & introduction • Conference Call -After Action Review feedback of pilot • Pilot Test - Receive & process clinical data from 62 project areas • Webinars - Option specific; open Q&A; • Develop After Action Report • Pilot Test – Project Area support & trouble shooting • Conference Calls - Individual project areas; follow up for Q&A • Conduct results briefings • Develop/administer feedback questionnaire • PHIN conference presentation • Apply lessons learned – CRA development, future pilot • CRA Development - Version 1.6 release • Selection of POC • Submit influenza vaccine doses administered data to CDC • Respond to feedback questionnaire • Identify & submit option choices • Finalize & submit clinic dates • Participate in After Action Review conference call • Review option-specific checklist • Obtain digital certificates

  13. 2007 Option Choices by Project Area Data Exchange Chicago American Samoa Web Entry aggregate NY City Marshall Islands Web Entry Detail Guam DC Mariana Islands Virgin Islands LA county Palau Puerto Rico FS Micronesia

  14. 2007 Summary Results • Pre-Planning • 100% (62/62) identified a POC • 100% (62/62) selected an Option • 85% (53/62) submitted both clinic dates • Pilot • 89% (55/62) submitted some data • 11% (7/62) did not submit any data • 64% (35/55) fully successful • Post-Pilot • 55 Respondents completed on-line feedback questionnaire • 61% (38/62) participated in After Action Review call

  15. Kansas Governor, Kathleen Sebelius, getting influenza vaccination in a Pilot Influenza Clinic, Kansas

  16. The Kansas Bee Mascot says: “Be wise, get immunized!”

  17. Timeliness Among All Options by Aggregation Method

  18. Data Submission Timeline All Options Note: N= 124 clinic dates

  19. Aggregation Method Among Web Entry Aggregate Users (Option 2) • IIS or other system : 23.5% 8/34 • Spreadsheet : 41.2% 14/34 • Paper based (reported) : 17.6% 6/34 • Paper based (did not report) : 17.6% 6/34

  20. Timeliness by System Reporting Technique – Options 1 and 2

  21. Need for More Than Systems!

  22. Option Choice Switching 5 Project Areas (PA) switched from original option choice to other choice when data reporting began • Option 3 to Option 1: 1 PA • Option 2 to Option 1: 2 PA • Option 3 to Option 2: 1 PA • Option 1 to Option 2: 1 PA

  23. Feedback Questionnaire Project Areas requested to complete anonymous, on-line feedback questionnaire Nine questions highlighting: Efficiency of communication from CDC Benefits of pilot test Issues/barriers encountered Feedback to improve future exercises

  24. Question: How beneficial was this pilot test to you in preparing for a pandemic influenza event in the future? 14 respondents : Very Beneficial 38 respondents : Somewhat Beneficial 3 respondents : Not Beneficial

  25. Question: What issues, if any, did you encounter while transmitting data to CDC? 18 respondents : digital certificate 12 respondents : file format 12 respondents : SDN (timing out); technical issues 9 respondents : Coordination with their local health departments

  26. After Action Review Call Feedback • Confirmed findings from Feedback Questionnaire • SDN timing out affected efficiency • Digital certificate process was a concern • Supplemented findings from Feedback Questionnaire • CRA was easy to use • CDC/CRA support was good (technical and project) • Need consistent communication by CDC • Distribution lists • Requesting all information at once • Leading implementer information • Support for expanded pilot for 2008 - 2009 influenza season

  27. Strategies for Addressing Challenges • Digital certificates: two parallel approaches • System design to allow lower level of security; expected late FY2009 • Internal decision memorandum of understanding • Timing-out user sessions: immediate issue corrected; reviewing configuration to avoid in future • Communications: • Training conference • Communication consistency • Small group calls

  28. 2007 Pilot Total Doses Administered 56,667 doses administered across all project areas Doses administered by age group: 6 – 23 Months: 6.4% (3,618) 2 – 19 Years: 23.0% (12,999) 20 – 49 Years: 22.6% (12,836) 50 – 64 Years : 24.4% (13,847) 65 Years +: 19.6% (11,119) Not identified 4.0% (2,248)

  29. Conclusions • Excellent willingness to participate across project areas • Vast majority (89%) of Project Areas able to collect, transmit, retrieve data • Nearly 2/3 of Project Areas submitted data within 48 hour time period • Challenges do exist, technical issues are being addressed • CRA able to accept, aggregate data submitted doses • Issues/barriers identified will assist in improving Pandemic Influenza preparedness • Project Areas supportive of broader/deeper testing during 2008 influenza season

  30. 2008 - 2009 Seasonal Influenza Exercise Objectives • Timeframe: October 1 - December 31, 2008 • Increase volume: to test system and operational capacities, Project Areas send data from a minimum of eight clinics during the four weeks • Track prioritization: to test tracking priority groups, Project Areas use proposed prioritization framework • Weekly reporting: to test weekly reporting capability, Project Areas send data for a minimum of four consecutive weeks • Tied to 2009 CDC PHEP continuation guidance biosurveillance requirement

  31. PHEP Biosurveillance Credit • PHEP biosurveillance credit • At least one of the eight clinics must be in a CRI/MSA location • At least one of the eight clinics must be in a non-CRI/MSA location • For Project Areas residing fully within a CRI/MSA location (i.e. LA, DC, Chicago, NYC) all eight clinics by default will be CRI-MSA with no non-CRI-MSA clinics reported • For Project Areas of the Pacific Islands and Territories, Puerto Rico, and the Virgin Islands, which do not have designated CRI-MSA locations, all eight clinics will be non-CRI-MSA with no CRI-MSA reported.

  32. DAX Status • Release of CRA v.1.8 development is complete; testing underway • Exercise planning underway • Vaccine Safety and Doses Administered Conference concluded 08/22/08 • Project Areas have submitted POCs • Projects Areas are selecting Option choices

  33. Acknowledgement • Collaborative effort among: • National Center for Immunization and Respiratory Diseases (NCIRD) – Immunization Services Division • National Center for Public Health Informatics (NCPHI) – Division of Emergency Preparedness and Response; CRA Team • Coordinating Office of Terrorism Preparedness and Emergency Response (COTPER) – Division of State and Local Readiness • PHEP Grantees and Project Areas – Points of Contact

  34. "The findings and conclusions in this report are those of the authors and do not necessarily represent the official positions of the Centers for Disease Control and Prevention."

  35. Questions?

More Related